𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A brief pain diary for ambulatory patients with advanced cancer : Acceptability and validity

✍ Scribed by Elizabeth Maunsell; Pierre Allard; Michel Dorval; Johanne Labbé

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
140 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

Undertreatment of pain is common among ambulatory patients with advanced cancer. available pain assessment tools are complex and not easy to use in ambulatory care settings.

Methods:

The authors developed and assessed the acceptability and psychometric properties of a simple, brief 4-week pain diary for ambulatory care assessing 3 indicators: current pain intensity on rising and retiring, number of daily rescue doses, and weekly impact of pain on quality of life. selected european organization for research and treatment (eortc) quality of life questionnaire subscales were administered once concurrently for validation purposes. subjects were 98 adult french-speaking ambulatory patients with advanced cancers who were on opioids, free of apparent cognitive impairment, and recruited through 2 oncology clinics in quebec city, quebec, canada.

Results:

In the first 3 weeks, > or =80% of patients completed all requested diary data. internal consistencies of the 5-item scale assessing pain impact on quality of life were 0.87-0.92 over the study period. pain intensity predicted both increased use of rescue doses and negative pain impact on quality of life. this latter scale was also responsive to decreases in pain intensity over 1-week intervals. as hypothesized, pain intensity, rescue doses, and pain impact on quality of life correlated with eortc scale scores. pain intensity correlated most strongly with the eortc pain and global quality of life scales (r = 0.65 and -0.55, respectively).

Conclusions:

This diary is simple, very brief, acceptable to patients, and appears to be valid. it can thus likely be used to monitor pain management for advanced cancer patients.

📜 SIMILAR VOLUMES

Pain treatment and outcomes for patients
Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home
✍ Sebastiano Mercadante 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## BACKGROUND. A small sample size, a high rate of exclusions, inadequate follow-up in different settings, and a lack of comparison with previous levels of analgesia have recently been reported to be the principal limitations of the World Health Organization (WHO) guidelines regarding cancer pain.

Phase II study of a modified combination
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer
✍ Içli, Fikri; Karaoguz, Handan; Akbulut, Hakan; Dinçol, Dilek; Demirkazik, Ahmet; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Background: Based on the promising results of eap (etoposide, doxorubicin, and cisplatin) combination, a phase ii study of modified eap combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival. ## Method: Fifty-two consecutive patients

Use of the subcutaneous route for the ad
Use of the subcutaneous route for the administration of narcotics in patients with cancer pain
✍ Eduardo Bruera; C. Brenneis; M. Michaud; R. Bacovsky; S. Chadwick; A. Emeno; N. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 1 views

From February 1985 until January 1987, 108 consecutive patients with pain due to advanced cancer requiring parenteral narcotics were treated with a subcutaneous infusion of morphine (62 patients) or hydromorphone (46 patients). Mean maximal daily dose of morphine and hydromorphone was 305 mg (range,

The addition of an audiocassette recordi
The addition of an audiocassette recording of a consultation to written recommendations for patients with advanced cancer : A randomized, controlled trial
✍ Eduardo Bruera; Edith Pituskin; Kathryn Calder; Catherine M. Neumann; John Hanso 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## BACKGROUND. Communication between physicians and advanced cancer patients is frequently difficult. Patients often report poor levels of satisfaction with communication. The purpose of this study was to assess the impact on patients' recall of and overall satisfaction with their consultation by t

Phase II trial of a 75-mg/m2 dose of doc
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer
✍ Vincent A. Miller; James R. Rigas; Prudence A. Francis; Stefan C. Grant; Katheri 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

## Background. A prior Phase I1 study of a 100-mg/m2 dose of docetaxel conducted at the Memorial Sloan-Kettering Cancer Center (New York, NY) demonstrated a 38% response rate with grade 3 or 4 neutropenia in 76% of the patients and a grade 2 or greater rash or infusionrelated reaction in 41% and 3